What Fast Tracking the COVID-19 Vaccine Means for the Future of Biopharmaceuticals

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

The world’s largest trade association, Biotechnology Innovation Organization (BIO) represents over 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations spanning the United States and more than 30 other nations. A proactive voice of science and for science that will drive a “bio revolution”, BIO is committed to speaking up for the millions of families around the globe who depend upon their success, driving a revolution that aims to cure patients, protect our climate, and nourishes humanity by:

  • Uniting and empowering biotech innovators and their ecosystem to improve lives
  • Removing barriers to innovation
  • Championing broad access to biotech breakthroughs and scientific equality
  • Catalyzing resilient and sustainable bio-based economies

Dr. Jeremy Levin, Chairman & CEO of Ovid Therapeutics Inc., and BIO’s Executive Committee Board Chair, joins Kevin Stevenson, host of MarketScale’s I Don’t Care podcast, to discuss his company, which concentrates on discovering cures for rare diseases of the brain, why the primary focus of his career has been on finding medicines, and BIO’s role in the development of a COVID-19 vaccine.

“I joined BIO with the idea that new medicines are important to people—they’re important to you, important to me. I wanted us to put the track of the industry only on finding new medicines to cure diseases. When COVID hit, the biotech industry stepped forward,” stated Levin. “This is not one company—this is multiples companies. This is not one approach to vaccines—there are at least six different approaches. This is not simply companies making products—you’ve got to have a safe drug and an effective drug. And we have one arbiter for that, and I am proud to work with them every day of the week—that’s the FDA.”

Listen to Previous Episodes of MarketScale’s I Don’t Care Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

digital freight invoicing
ODeX Is Leading the Charge in Digital Freight Invoicing
April 24, 2025

Global shipping continues to grapple with fragmented billing processes, often delaying cargo movement. According to McKinsey, adopting an electronic bill of lading could save $6.5 billion in direct costs and enable $40 billion in global trade. As vessels carry goods for thousands of shippers per voyage, the administrative burden of managing and reconciling invoices…

Read More
Human Intelligence Movement
Just Thinking… about Reimagining Education for the AI Era with the Human Intelligence Movement
April 24, 2025

As artificial intelligence reshapes education, work, and daily life, educators are grappling with how to prepare students for a future where human skills—not just knowledge—will be paramount. In fact, a growing number of reports highlight that employers increasingly value collaboration, communication, and emotional intelligence over memorized content. Amid this transformation, the Human Intelligence Movement…

Read More
The Value of a Restoration Team with Healthcare Experience
The Value of a Restoration Team with Healthcare Experience
April 24, 2025

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

Read More
Science of reading
Educators Must Combine 1:1 Tutoring with the Science of Reading to Close the Reading Gap
April 23, 2025

Coming out of the COVID-19 pandemic, the education system faced a seismic shift. Learning loss, especially in foundational literacy, was a national crisis. In 2024, only 31% of fourth graders in the U.S. were reading proficiently, according to the National Assessment of Educational Progress (NAEP). Meanwhile, tutoring exploded as a top strategy to recover…

Read More